BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36725110)

  • 1. The biology of E-selectin ligands in leukemogenesis.
    Ales E; Sackstein R
    Adv Cancer Res; 2023; 157():229-250. PubMed ID: 36725110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives.
    Sackstein R
    Curr Opin Hematol; 2011 Jul; 18(4):239-48. PubMed ID: 21546828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.
    Pachón-Peña G; Donnelly C; Ruiz-Cañada C; Katz A; Fernández-Veledo S; Vendrell J; Sackstein R
    Stem Cells; 2017 Apr; 35(4):1080-1092. PubMed ID: 27888602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.
    Dimitroff CJ; Lechpammer M; Long-Woodward D; Kutok JL
    Cancer Res; 2004 Aug; 64(15):5261-9. PubMed ID: 15289332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells.
    Merzaban JS; Burdick MM; Gadhoum SZ; Dagia NM; Chu JT; Fuhlbrigge RC; Sackstein R
    Blood; 2011 Aug; 118(7):1774-83. PubMed ID: 21659548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues.
    Munro JM; Lo SK; Corless C; Robertson MJ; Lee NC; Barnhill RL; Weinberg DS; Bevilacqua MP
    Am J Pathol; 1992 Dec; 141(6):1397-408. PubMed ID: 1281620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology.
    Silva M; Fung RKF; Donnelly CB; Videira PA; Sackstein R
    J Immunol; 2017 May; 198(9):3576-3587. PubMed ID: 28330896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration.
    Sackstein R
    Ann Biomed Eng; 2012 Apr; 40(4):766-76. PubMed ID: 22068886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
    Hanley WD; Burdick MM; Konstantopoulos K; Sackstein R
    Cancer Res; 2005 Jul; 65(13):5812-7. PubMed ID: 15994957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective expression of sialyl-Lewis x and Lewis a epitopes, putative ligands for L-selectin, on peripheral lymph-node high endothelial venules.
    Paavonen T; Renkonen R
    Am J Pathol; 1992 Dec; 141(6):1259-64. PubMed ID: 1281614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology.
    Sackstein R
    Glycobiology; 2016 Jun; 26(6):560-70. PubMed ID: 26933169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSGL-1 decorated with sialyl Lewis
    O'Dwyer M; Kirkham-McCarthy L; Cerreto M; Foà R; Natoni A
    Sci Rep; 2024 Jan; 14(1):1756. PubMed ID: 38243063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectin ligands on human melanoma cells.
    Miller N; Vile RG; Hart IR
    Glycoconj J; 1996 Feb; 13(1):33-43. PubMed ID: 8785485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding.
    Mondal N; Silva M; Castano AP; Maus MV; Sackstein R
    J Biol Chem; 2019 Nov; 294(48):18465-18474. PubMed ID: 31628196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins.
    Wagers AJ; Stoolman LM; Craig R; Knibbs RN; Kansas GS
    J Immunol; 1998 May; 160(10):5122-9. PubMed ID: 9590264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone.
    Sackstein R; Merzaban JS; Cain DW; Dagia NM; Spencer JA; Lin CP; Wohlgemuth R
    Nat Med; 2008 Feb; 14(2):181-7. PubMed ID: 18193058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selectin family of carbohydrate-binding proteins: structure and importance of carbohydrate ligands for cell adhesion.
    Cummings RD; Smith DF
    Bioessays; 1992 Dec; 14(12):849-56. PubMed ID: 1285423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells.
    Burdick MM; Chu JT; Godar S; Sackstein R
    J Biol Chem; 2006 May; 281(20):13899-905. PubMed ID: 16565092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between human eosinophils and neutrophils in the function and expression of sialic acid-containing counterligands for E-selectin.
    Bochner BS; Sterbinsky SA; Bickel CA; Werfel S; Wein M; Newman W
    J Immunol; 1994 Jan; 152(2):774-82. PubMed ID: 7506734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion.
    Stahn R; Schäfer H; Kernchen F; Schreiber J
    Glycobiology; 1998 Apr; 8(4):311-19. PubMed ID: 9499378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.